Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Fish and Richardson
Express Scripts
Cipla
QuintilesIMS
Chubb
Farmers Insurance
Daiichi Sankyo
Deloitte
Johnson and Johnson

Generated: January 23, 2018

DrugPatentWatch Database Preview

TRIMIPRAMINE MALEATE Drug Profile

« Back to Dashboard

Which patents cover Trimipramine Maleate, and what generic alternatives are available?

Trimipramine Maleate is a drug marketed by Crossmedika Sa, Elite Labs Inc, and Usl Pharma. and is included in five NDAs.

The generic ingredient in TRIMIPRAMINE MALEATE is trimipramine maleate. There are five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the trimipramine maleate profile page.
Drug patent expirations by year for TRIMIPRAMINE MALEATE
Pharmacology for TRIMIPRAMINE MALEATE
Medical Subject Heading (MeSH) Categories for TRIMIPRAMINE MALEATE

US Patents and Regulatory Information for TRIMIPRAMINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Crossmedika Sa TRIMIPRAMINE MALEATE trimipramine maleate CAPSULE;ORAL 208127-001 Apr 15, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Usl Pharma TRIMIPRAMINE MALEATE trimipramine maleate CAPSULE;ORAL 071283-001 Dec 8, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Elite Labs Inc TRIMIPRAMINE MALEATE trimipramine maleate CAPSULE;ORAL 077361-001 Aug 2, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Usl Pharma TRIMIPRAMINE MALEATE trimipramine maleate CAPSULE;ORAL 071284-001 Dec 8, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Crossmedika Sa TRIMIPRAMINE MALEATE trimipramine maleate CAPSULE;ORAL 208127-002 Apr 15, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Crossmedika Sa TRIMIPRAMINE MALEATE trimipramine maleate CAPSULE;ORAL 208127-003 Apr 15, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Elite Labs Inc TRIMIPRAMINE MALEATE trimipramine maleate CAPSULE;ORAL 077361-003 Aug 2, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Elite Labs Inc TRIMIPRAMINE MALEATE trimipramine maleate CAPSULE;ORAL 077361-002 Aug 2, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Usl Pharma TRIMIPRAMINE MALEATE trimipramine maleate CAPSULE;ORAL 071285-001 Dec 8, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Cipla
US Department of Justice
McKinsey
US Army
Dow
Fuji
Chubb
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot